A group of Italian biotech companies has recently entered the world race to contain and finally defeat the coronavirus, and are getting results. While the chronicles are full of Japanese miracle drugs and vaccine trials in the four corners of the world, Italian biotech is getting international recognition and is close to important trials.

“Perhaps more than other sectors, we are aware of what it means to face a pandemic,” said Riccardo Palmisano, president of Assobiotec-Federchimica, the trade association that brings together over 130 companies involved in biotechnology and pharmaceuticals (as well as agriculture and the environment).